News
News
- Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and Flu, and the Clinical Severity of Such Infections
08/07/2020 / 18:12 - GlobeNewswire - RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico
08/06/2020 / 13:00 - GlobeNewswire - Falcon Strikes High-Grade Gold at Its Spitfire & Sunny Boy Claims, Merritt, B.C.
08/04/2020 / 18:05 - Newsfile Corp - Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe
08/04/2020 / 16:38 - GlobeNewswire - Challenged Athletes Foundation (CAF) Reimagines Fall Events to Raise Millions of Dollars
08/04/2020 / 16:00 - GlobeNewswire - Data from Diabits Shows Lockdown’s Unexpected Benefit for Diabetes Patients
08/04/2020 / 15:00 - GlobeNewswire - Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe
08/04/2020 / 12:30 - GlobeNewswire - Amarin Reports Second Quarter 2020 Financial Results and Provides Update on Operations
08/04/2020 / 12:00 - GlobeNewswire - Stingray Music Launches with Six Partners in the US
08/03/2020 / 14:30 - GlobeNewswire - CYTTA Corp Announces Sale of Core Products to New Market Vertical - Providing Fortune 50 Utility Companies with Live-Streamed Inspections
08/03/2020 / 14:00 - GlobeNewswire
Real-time